Last reviewed · How we verify

NCT03636334: LIGHT

Learning Implementation of Guideline-based Decision Support System for Hypertension Treatment (LIGHT)

Status unknown NA Last updated 15 April 2021
What this trial tests

NA trial testing Computer-based decision support system in Hypertension in 10,000 participants. Status unknown.

Timeline
21 August 2019
Primary endpoint
30 March 2022
30 March 2022

Quick facts

Lead sponsorChina National Center for Cardiovascular Diseases
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment10,000
Start date21 August 2019
Primary completion30 March 2022
Estimated completion30 March 2022
Sites3 locations across China

Drugs / interventions tested

Conditions studied

Sponsor

China National Center for Cardiovascular Diseases — full company profile →

Who can join

18 and older, any sex, with Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This trial aims to evaluate the effectiveness of a guideline-based decision support system for hypertension management by physicians at primary health care (PHC) centers in China in order to improve the delivery of appropriate treatment and blood pressure (BP) control for hypertensive individuals.

Publications & conference data

6 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Learning implementation of a guideline based decision support system to improve hypertension treatment in primary care in China: pragmatic cluster randomised controlled trial.
    Song J, Wang X, Wang B, Ge Y, et al · · 2024 · cited 12× · PMID 39043397 · DOI 10.1136/bmj-2023-079143
  2. Effectiveness of a clinical decision support system for hypertension management in primary care: study protocol for a pragmatic cluster-randomized controlled trial.
    Song J, Wang X, Wang B, Gao Y, et al · · 2022 · cited 8× · PMID 35578345 · DOI 10.1186/s13063-022-06374-x
  3. Development of a machine learning-based model for predicting individual responses to antihypertensive treatments.
    Yi J, Wang L, Song J, Liu Y, et al · · 2024 · cited 6× · PMID 38555240 · DOI 10.1016/j.numecd.2024.02.014
  4. Clinical Decision Support System, Antihypertensive Treatment Intensification, and Blood Pressure Control: A Post Hoc Secondary Analysis of a Cluster Randomized Trial.
    Song J, Liu Y, Shang Q, Liu J, et al · · 2026 · PMID 42201734 · DOI 10.1001/jamanetworkopen.2026.14858
  5. Rationale And Design of The Learning Implementation of Guideline-Based Decision Support System For Hypertension Treatment (LIGHT) Trial And LIGHT-ACD Trial
    Song J, Wang X, Wang B, Gao Y, et al · · 2021 · DOI 10.21203/rs.3.rs-665345/v1
  6. Rationale and design of the Learning Implementation of Guideline-based decision support system for Hypertension Treatment (LIGHT) Trial and LIGHT-ACD Trial
    Song J, Wang X, Wang B, Gao Y, et al · · 2021 · DOI 10.1101/2021.03.11.21253427

Verify or expand the search:

Other recruiting trials for Hypertension

Currently open trials in the same condition.

Other China National Center for Cardiovascular Diseases trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03636334.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing